Finally, in order to fully understand the role of ZNF423 in either breast cancer risk or response to anti-neoplastic drug therapy, additional experiments will need to be performed to identify additional ZNF423-regulated genes or pathways which could be regulated in a similar SNP and drug-dependent fashion. The gene discussed is ZNF423; the disease is breast cancer.